Home > Resources > Videos > Painting a Safer Europe

Painting a Safer Europe

Life can be dangerous! But something gets safer every day. Dangerous chemicals in the things we use are being replaced, to make our lives in the European Union a little safer. Inform yourself:
http://echa.europa.eu/chemicals-in-ou...

Spotlight

Cara Therapeutics

Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat pain, inflammation and pruritus. Cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's most advanced patented compound, CR845, is currently undergoing clinical testing for acute pain and uremic pruritus. This compound possesses analgesic, anti-inflammatory and antipruritic activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.

OTHER VIDEOS

Controlling exothermic reactions with AVA Lab Control Software

video | March 30, 2023

AVA Lab Control Software allows you to automate your chemistry by remotely controlling the devices connected to your jacketed lab reactor with full process data logging....

Watch Now

Processing For Modelling Hydrogen Atoms In Protein Structures

video | March 22, 2023

Neutron Crystallography Data Collection and Processing for Modelling Hydrogen Atoms in Protein Structures....

Watch Now

Phosphoproteomic Strategy for Profiling Osmotic Stress Signaling

video | March 17, 2023

Presented here is a phosphoproteomic approach, namely stop and go extraction tip based phosphoproteomic, which provides high-throughput and deep coverage of Arabidopsis phosphoproteome. This approach delineates the overview of osmotic stress signaling in Arabidopsis....

Watch Now

In-cell Fast Photochemical Oxidation of Proteins

video | March 14, 2023

Characterizing Cellular Proteins with In-cell Fast Photochemical Oxidation of Proteins - a 2 minute Preview of the Experimental Protocol...

Watch Now

Controlling exothermic reactions with AVA Lab Control Software

video | March 30, 2023

AVA Lab Control Software allows you to automate your chemistry by remotely controlling the devices connected to your jacketed lab reactor with full process data logging....

Watch Now

Processing For Modelling Hydrogen Atoms In Protein Structures

video | March 22, 2023

Neutron Crystallography Data Collection and Processing for Modelling Hydrogen Atoms in Protein Structures....

Watch Now

Phosphoproteomic Strategy for Profiling Osmotic Stress Signaling

video | March 17, 2023

Presented here is a phosphoproteomic approach, namely stop and go extraction tip based phosphoproteomic, which provides high-throughput and deep coverage of Arabidopsis phosphoproteome. This approach delineates the overview of osmotic stress signaling in Arabidopsis....

Watch Now

In-cell Fast Photochemical Oxidation of Proteins

video | March 14, 2023

Characterizing Cellular Proteins with In-cell Fast Photochemical Oxidation of Proteins - a 2 minute Preview of the Experimental Protocol...

Watch Now
MORE VIDEOS

Spotlight

Cara Therapeutics

Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat pain, inflammation and pruritus. Cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's most advanced patented compound, CR845, is currently undergoing clinical testing for acute pain and uremic pruritus. This compound possesses analgesic, anti-inflammatory and antipruritic activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.

Events